Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The role of regulatory T cells in neurodegenerative diseases.
Teriflunomide (AUBAGIO). Multiple sclerosis: just a metabolite of leflunomide.
Melanocortins as Innovative Drugs for Ischemic Diseases and Neurodegenerative Disorders: Established Data and Perspectives.
The long-term cost-effectiveness of the use of Functional Electrical Stimulation for the correction of dropped foot due to upper motor neuron lesion.
Treatment of the chronic progressive form of multiple sclerosis with a combination of cyclophosphamide and prednisone.
Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis.
Origin and evolution of deep brain stimulation.
Fingolimod (Gilenya) licence extended
Afferent visual pathways in multiple sclerosis: a review.
Lack of response to rituximab therapy in patients with neuromyelitis optica: Response to Kim and Kim.
Longitudinal Penalized Functional Regression for Cognitive Outcomes on Neuronal Tract Measurements.
Alemtuzumab Therapy for Multiple Sclerosis.
T cell deficiency in spinal cord injury: altered locomotor recovery and whole-genome transcriptional analysis.
Cannabinoids control spasticity and tremor in a multiple sclerosis model.
Hyperconnectivity is a Fundamental Response to Neurological Disruption.
[The role of chronic venous insufficiency in the pathogenesis of brain diseases].
Deaths and disability from natalizumab are no longer tolerable: No - (they can be avoided).
[Research progress of the selective sphingosine-1-phosphate receptor 1 agonists].
Pre-existing T- and B-cell defects in one progressive multifocal leukoencephalopathy patient.
NMO spectrum presenting as partial myelitis.
Cutting Edge: TNF Receptor-Associated Factor 4 Restricts IL-17-Mediated Pathology and Signaling Processes.
Lysoglycerophospholipids in chronic inflammatory disorders: The PLA(2)/LPC and ATX/LPA axes.
Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.
A Genome-Wide Integrative Genomic Study Localizes Genetic Factors Influencing Antibodies against Epstein-Barr Virus Nuclear Antigen 1 (EBNA-1).
Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation.

Pages